Firsocostat

Firsocostat is an acetyl-CoA carboxylase inhibitor that functions in the liver. Its original designation was GS-0976. It was discovered by Nimbus Therapeutics. The drug is under development by Gilead as a treatment for non-alcoholic fatty liver disease.